Results 11 to 20 of about 45,205 (210)
Androgenic alopecia; the risk–benefit ratio of Finasteride [PDF]
Journal of Mind and Medical Sciences, 2018 Finasteride is currently approved and largely used as a therapeutic option for androgenetic alopecia. Apparently a safe drug and effective at the onset, several concerns appeared over time regarding the frequency and magnitude of finasteride adverse ...
David L. Rowland +6 more
doaj +4 more sources
Clinical profile of androgenic alopecia and its association with cardiovascular risk factors
Indian Journal of Dermatology, 2019 Context: Androgenic alopecia (AGA) is a hereditary androgen-dependent disorder, characterized by gradual conversion of terminal hair into miniaturized hair and defined by various patterns. Common age group affected is between 30 and 50 years.
Rita V Vora +3 more
doaj +2 more sources
Systemic therapy of androgenic alopecia
Vestnik Dermatologii i Venerologii, 2017 The article describes the literature sources related to the efficacy of systemic therapy of androgenic alopecia in female and male.
I. N. Kondrakhina, A. N. Mareeva
doaj +2 more sources
Efficacy of platelet-rich plasma in treatment of androgenic alopecia
Asian Journal of Transfusion Science, 2015 Background: Platelet-rich plasma (PRP) has shown remarkable beneficial effects without any major adverse reactions in the treatment of androgenic alopecia.
Parul Singhal +3 more
doaj +2 more sources
Molecules, 2021 Men with early-onset androgenetic alopecia are characterized by hormonal profiles similar to those observed in women with polycystic ovary syndrome. The purpose of this research was to investigate levels of cardiometabolic risk factors in 3-hydroxy-3 ...
Robert Krysiak +2 more
doaj +2 more sources
Use of body and beard donor hair in surgical treatment of androgenic alopecia
Indian Journal of Plastic Surgery, 2013 Objectives: Follicular unit transplant is a widely used surgical treatment for androgenic alopecia. However, for patients with extensive hair loss (Norwood 5 and above), scalp donor hair are not sufficient to cover all areas of baldness.
Arvind Poswal
doaj +2 more sources
Is There a Relationship between Androgenic Alopecia and Benign Prostatic Hyperplasia?
Acta Medica Iranica, 2015 Androgenic alopecia as a physiologic process and benign prostatic hyperplasia (BPH) as a pathologic process in the older population are androgen-dependent processes influenced by 5-alpha reductase enzyme which converts testosterone to dihydrotestosterone.
Ladan Dastgheib +4 more
doaj +1 more source
Pakistan Armed Forces Medical JournalObjective: To compare mean hair density in healthy adult versus androgenic alopecia patient’s scalp in male Pakistani population Study Design: Comparative Cross Sectional Study Place and Duration of Study: Combined Military Hospital, Jhelum ...
Zaaraa Javed +3 more
doaj +2 more sources
Conventional and novel stem cell based therapies for androgenic alopecia
Stem Cells and Cloning: Advances and Applications, 2017 Dodanim Talavera-Adame,1 Daniella Newman,2 Nathan Newman1 1American Advanced Medical Corp. (Private Practice), Beverly Hills, CA, 2Western University of Health Sciences, Pomona, CA, USA Abstract: The prevalence of androgenic alopecia (AGA) increases with
Talavera-Adame D, Newman D, Newman N
doaj +1 more source
Human Stem Cell Use in Androgenetic Alopecia: A Systematic Review
Cells, 2023 Androgenetic alopecia is a condition that results in hair loss in both men and women. This can have a significant impact on a person’s psychological well-being, which can lead to a decreased quality of life.
Katarzyna Krefft-Trzciniecka +3 more
doaj +1 more source